Skip to main content
Clinical Trials/NCT04790071
NCT04790071
Completed
Not Applicable

Does Dry Needling Treatment Make an Extra Contribution to Conventional Treatment in Hemiplegic Shoulder Pain?

Kars State Hospital2 sites in 1 country46 target enrollmentOctober 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Myofascial Pain
Sponsor
Kars State Hospital
Enrollment
46
Locations
2
Primary Endpoint
Change in visual analog scale score
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

To evaluate the efficacy of dry needling therapy on shoulder pain and upper extremity functions in hemiplegic patients.

Detailed Description

The myofascial trigger point is an overlooked issue in hemiplegic shoulder pain. Our aim in this study is to evaluate whether dry needling treatment contributes to the conventional treatment approach.

Registry
clinicaltrials.gov
Start Date
October 1, 2022
End Date
April 9, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Kars State Hospital
Responsible Party
Principal Investigator
Principal Investigator

Fatih Bagcier

Study Principal Investigator

Kars State Hospital

Eligibility Criteria

Inclusion Criteria

  • The patients included in the study were aged between 30-60 years, with at least a 3-month history of hemorrhagic or ischemic stroke.

Exclusion Criteria

  • if they had severe difficulty in communication
  • had received a corticosteroid injection within 3 months prior to enrollment
  • had bleeding diathesis, a history of shoulder surgery
  • a preexisting painful shoulder disorder, or had a cardiac pacemaker.

Outcomes

Primary Outcomes

Change in visual analog scale score

Time Frame: 3 months

It grades pain of the patients between 0 and 10 points. Higher scores represent a worse outcome

Change in Quick The Disabilities of the Arm, Shoulder and Hand (DASH) Questionnaire score

Time Frame: 3 months

The Quick DASH is an 11-item measure of the magnitude of disability and symptoms specific to the upper extremity. The first 6 items measure the degree of difficulty in performing various physical activities because of a shoulder, arm, and hand problem, and the other 5 items related to quality of sleeping, social activities, and daily activities, and the intensity of pain and numbness.

Change in Fugl-Meyer Assessment score

Time Frame: 3 months

The FM scale is a 226-point multi-item Likert-type scale developed as an evaluative measure of recovery from hemiplegic stroke. It is divided into 5 domains: motor function, sensory function, balance, joint range of motion, and joint pain. Each domain contains multiple items, each scored on a 3-point ordinal scale (0 = cannot perform, 1 = performs partially, 2 = performs fully).

Change in range of motion

Time Frame: 3 months

Shoulder range of motion of the patients is evaluated in abduction, flexion, and external rotation. Higher measurements represent a better outcome

Study Sites (2)

Loading locations...

Similar Trials